Marketing-authorisation holder · Norway
Leo Pharma AS
112 medicines in 6 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Norway
112 medicines in 6 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 112
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADBRY150mg/ml · Injectable | Tralokinumab | United States | Marketed | 2021 |
| Adbry300mg/2ml · Injection | Tralokinumab | United States | Marketed | 2024 |
| Adtralza | Tralokinumab | EU (EMA) | Authorised | 2021 |
| ADTRALZASoluzione iniettabile | Tralokinumab | Italy | Authorised | |
| ADTRALZA 150 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA150 mg · Solución inyectable | Tralokinumab | Spain | Marketed | 2021 |
| ADTRALZA 300 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA300 mg · Solución inyectable | Tralokinumab | Spain | Marketed | 2023 |
| ADVANTANCrema | Metilprednisolona aceponato | Italy | Authorised | |
| Advantan 1 mg/g kremakrema | Metilprednizolonaceponat | Croatia | Marketed | 2019 |
| Advantan 1 mg/g mastmast | Metilprednizolonaceponat | Croatia | Marketed | 2019 |
| ADVENTAN 1 mg/g CREMA0,1 g · Crema | Metilprednisolona aceponato | Spain | Marketed | 1994 |
| ADVENTAN 1 mg/g EMULSION CUTANEA100 mg · Emulsión cutánea | Metilprednisolona aceponato | Spain | Marketed | 1999 |
| ADVENTAN 1 mg/g POMADA0,1 g · Pomada | Metilprednisolona aceponato | Spain | Marketed | 1994 |
| ADVENTAN 1 mg/g UNGÜENTO0,1 g · Pomada | Metilprednisolona aceponato | Spain | Marketed | 1994 |
| ANZUPGOCrema | Delgocitinib | Italy | Authorised | |
| Anzupgo | Delgocitinib | EU (EMA) | Authorised | 2024 |
| ANZUPGO2% · Cream | Delgocitinib | United States | Marketed | 2025 |
| ANZUPGO 20 MG/G CREMA20 mg · Crema | Delgocitinib | Spain | Marketed | 2024 |
| CLARAL 1 mg/g CREMA1,0 mg · Crema | Diflucortolone | Spain | Marketed | 1979 |
| DAIVOBET 50 microgramos/0,5 mg/g GEL50 µg + 0,5 mg · GEL | Calcipotriol, Betamethasone | Spain | Marketed | 2008 |
| DAIVOBET 50 microgramos/ 0,5 mg/g POMADA0,5 mg + 50 µg · Pomada | Betamethasone, Calcipotriol | Spain | Marketed | 2002 |
| DAIVOBET 50 MICROGRAMOS/0,5 MG/G POMADA0,5 mg + 50 µg · Pomada | Betamethasone, Calcipotriol | Spain | Marketed | 2026 |
| Daivobet 50 mikrograma/g + 0,5 mg/g gelgel | Calcipotriol, Betamethasone | Croatia | Marketed | 2017 |
| DAIVONEXCrema | Calcipotriol | Italy | Authorised | |
| DAIVONEX 50 MICROGRAMOS/G CREMA50 µg · Crema | Calcipotriol | Spain | Marketed | 1996 |
| DESONATE0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · GEL | Desonide | United States | Not marketed | 2006 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 37 | 35 | 2 | CompaniesAll medicines |
| Romania | 25 | 0 | 25 | CompaniesAll medicines |
| Italy | 22 | 22 | 0 | CompaniesAll medicines |
| United States | 17 | 17 | 0 | CompaniesAll medicines |
| Croatia | 6 | 6 | 0 | CompaniesAll medicines |
| European Union (EMA) | 5 | 5 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, France, Netherlands, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brønnøysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Licence: Norwegian Licence for Open Government Data
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.